LLY

974.96

-1.19%↓

JNJ

222.47

-0.89%↓

ABBV

202.58

-1.21%↓

UNH

369.71

+0.7%↑

AZN

182.23

-1.36%↓

LLY

974.96

-1.19%↓

JNJ

222.47

-0.89%↓

ABBV

202.58

-1.21%↓

UNH

369.71

+0.7%↑

AZN

182.23

-1.36%↓

LLY

974.96

-1.19%↓

JNJ

222.47

-0.89%↓

ABBV

202.58

-1.21%↓

UNH

369.71

+0.7%↑

AZN

182.23

-1.36%↓

LLY

974.96

-1.19%↓

JNJ

222.47

-0.89%↓

ABBV

202.58

-1.21%↓

UNH

369.71

+0.7%↑

AZN

182.23

-1.36%↓

LLY

974.96

-1.19%↓

JNJ

222.47

-0.89%↓

ABBV

202.58

-1.21%↓

UNH

369.71

+0.7%↑

AZN

182.23

-1.36%↓

Accueil・Liste d'Actions・Pfizer

Pfizer

Fermé

SecteurSoins de santé

26.46 -0.15

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.16

Max

26.7

Chiffres clés
By Trading Economics
Revenu	-5.2B -1.6B
Ventes	903M 18B
P/E Moyenne du Secteur	19.338 49.8
BPA	0.66
Rendement du dividende	6.53
Marge bénéficiaire	-9.387
Employés	75,000
EBITDA	-4.9B 756M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+10.14% upside

Dividendes
By Dow Jones
Rendement du dividende Moyenne du Secteur	6.53% 2.25%
Prochains Résultats	4 août 2026
Date du Prochain Dividende	12 juin 2026
Date du Prochain Détachement de Dividende	8 mai 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-2B 150B
Ouverture précédente	26.61
Clôture précédente	26.46

Sentiment de l'Actualité

By Acuity

42%

58%

135 / 347 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

22.855 / 23.85 Support & Résistance

Pfizer Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 mai 2026, 11:31 UTC

Résultats

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 mai 2026, 18:12 UTC

Résultats

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mai 2026, 13:54 UTC

Résultats

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mai 2026, 12:35 UTC

Résultats

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 mai 2026, 11:06 UTC

Résultats

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 mai 2026, 10:47 UTC

Résultats

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 mai 2026, 10:47 UTC

Résultats

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 mai 2026, 10:46 UTC

Résultats

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 mai 2026, 10:46 UTC

Résultats

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer Reaffirms 2026 Guidance >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer 1Q Rev $14.5B >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer 1Q EPS 47c >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer 1Q Net $2.69B >PFE

5 mai 2026, 10:45 UTC

Résultats

Pfizer 1Q Adj EPS 75c >PFE

5 mai 2026, 10:36 UTC

Actions en Tendance

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 avr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 avr. 2026, 20:07 UTC

Acquisitions, Fusions, Rachats

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mars 2026, 11:02 UTC

Market Talk

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mars 2026, 12:50 UTC

Résultats

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mars 2026, 11:18 UTC

Résultats

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mars 2026, 09:43 UTC

Actions en Tendance

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 févr. 2026, 21:51 UTC

Résultats

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 févr. 2026, 21:17 UTC

Résultats

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 févr. 2026, 21:36 UTC

Résultats

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 févr. 2026, 19:56 UTC

Résultats

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 févr. 2026, 19:46 UTC

Résultats

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 févr. 2026, 17:35 UTC

Résultats

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 févr. 2026, 17:30 UTC

Résultats

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Comparaison

Variation de prix

Pfizer prévision

Objectif de Prix

By TipRanks

10.14% hausse

Prévisions sur 12 Mois

Moyen 29.22 USD 10.14%

Haut 36 USD

Bas 25 USD

Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

22 ratings

Achat

Maintien

Vente

Basé sur 22 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

22.855 / 23.85Support & Résistance

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

135 / 347Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.